area of the top fusion algorithm was greater than the mean receiver operating characteristic area of dermatologists (0.86 vs. 0.71, P = .001).
Limitations: The dataset lacked the full spectrum of skin lesions encountered in clinical practice, particularly banal lesions. Readers and algorithms were not provided clinical data (eg, age or lesion history/symptoms). Results obtained using our study design cannot be extrapolated to clinical practice.
Conclusion:
Deep learning computer vision systems classified melanoma dermoscopy images with accuracy that exceeded some but not all dermatologists. ( J Am Acad Dermatol 2018;78:270-7.)
Key words: computer algorithm; computer vision; dermatologist; International Skin Imaging Collaboration; International Symposium on Biomedical Imaging; machine learning; melanoma; reader study; skin cancer.
The early diagnosis of melanoma remains challenging. 1 Estimates of the sensitivity of dermatologists for melanoma in reader studies were 70% for the Nevisense trial 2 and 78% for the MelaFind trial. 3 In addition, because nonphysicians detect the majority of melanomas 4 and because population-based melanoma screening by clinicians is not recommended in the United States, 5 there is not only interest in the development of automated image analysis algorithms to help dermatologists classify dermoscopic images, but also to aid laypersons or nondermatology physicians in melanoma detection. [6] [7] [8] [9] [10] [11] [12] [13] To date, the lack of a large, public dataset of skin images has limited the ability to directly compare the diagnostic performance of competing automated image analysis approaches against clinicians.
To address this limitation, the International Skin Imaging Collaboration (ISIC) Melanoma Project created an open-access archive of dermoscopic images of skin lesions for education and research. 14 We describe the melanoma classification results from a challenge conducted by the ISIC Archive 15 at the 2016 International Symposium on Biomedical Imaging (ISBI) involving 25 competing teams. 16 We further performed a companion reader study with 8 experienced dermatologists on a subset of images; these results served as a reference comparator to the automated algorithm approaches.
MATERIALS AND METHODS

Institutional review board approval
Institutional review board approval was obtained at Memorial Sloan Kettering and the study was conducted in accordance with the Helsinki Declaration. [19. 8% melanomas]) sets. All melanomas and a majority of the nevi/lentigines (n = 869, 84%) had been histopathologically examined. Nonhistopathologically examined nevi (n = 162) originated from a longitudinal study of children; selection from this dataset was biased to include lesions with the largest diameters, and all images were reviewed by $2 dermatologists to confirm their benign nature. 19 Images used in this challenge were obtained with multiple camera/dermatoscope combinations and originated from [12 dermatology clinics around the world.
Twenty-five teams participated in the challenge, all of which used deep learning, a form of machine learning that uses multiple processing layers to automatically identify increasingly abstract concepts present in data. Computer algorithms were ranked using average precision, which corresponds to the
CAPSULE SUMMARY d
Computer vision has shown promise in medical diagnosis. 
15,18
Reader study A reader study was performed on 50 randomly selected melanomas (31 invasive, 19 in situ) and 50 benign neoplasms (44 nevi, 6 lentigines) from the 379 test images. Nonhistopathologically examined benign lesions were excluded from this image set. The median (range) Breslow depth for the invasive melanomas was 0.70 mm (0.10-2.06 mm). Eight experienced dermatologists from 4 countries were invited on May 13, 2016 , and all agreed to participate. The mean (range) number of years of (1) postresidency clinical experience and (2) use of dermoscopy among readers was 13 years (range, 3-31 years) and 13.5 years (range, 6-27 years), respectively, and all had a primary clinical focus on skin cancer. For each dermoscopic image, readers: (1) classified the lesion (benign vs. malignant) and (2) indicated management (obtaining a biopsy specimen or observation/ reassurance). Readers were blinded to diagnosis and clinical images/metadata. There were no time restrictions and participants could complete evaluations over multiple sittings.
Automated predictions
We report the performance of the 5 top-ranked individual algorithms of the ISBI 2016 Challenge on the reader set of 100 dermoscopic images. In addition, we implemented 5 methods of fusing all automated predictions from the 25 participating teams in the ISBI challenge into a single prediction. These methods included 2 nonlearned approaches (prediction score averaging and voting) and 3 machine learning methods: greedy ensemble fusion, 20 linear binary support vector machine (SVM), and nonlinear binary SVM (histogram intersection kernel) (Supplemental materials; available at http:// www.jaad.org). 21 Test set images that were not involved in the reader study (n = 279) were used to train fusion methods; fusion algorithms were ranked by average precision on the reader set of 100 images.
Statistical analysis
The primary outcomes and measures were sensitivity, specificity, and area under the receiver operating characteristic (ROC) curves. Sensitivity in classification was defined as the percentage of melanomas that were correctly scored as malignant. Sensitivity in management decision was defined as the percentage of melanomas for which obtaining a biopsy specimen was correctly indicated. Specificity in classification was defined as the percentage of benign lesions that were correctly scored as benign. Specificity in management decision was defined as the percentage of benign lesions that were correctly indicated for observation/reassurance.
Computers submitted predictions between 0.0 and 1.0, with 0.5 used as a dichotomous threshold in the ISBI Challenge: values #0.5 were benign and values[0.5 to 1.0 were malignant. For analyses here, we considered scores closer to 0 to indicate a higher probability of a benign diagnosis and scores closer to 1 to indicate a higher probability of malignancy.
As ground truth data provided to participants in the ISBI 2016 challenge was restricted to classification (benign vs. malignant) and did not include management data (obtaining a biopsy specimen vs. observation/reassurance), we chose classification performance as the primary outcome. To inform clinical practice, however, we also compared management decisions of dermatologists to computer classification performance as an exploratory outcome; another rationale for reporting management decision performance was that most studies comparing human readers to computers have used management decision, and not classification, as the primary outcome. Our primary comparison between readers and computers was specificity at average dermatologist sensitivity; the secondary comparison between readers and computers was ROC area of the algorithm and mean ROC area of the dermatologists.
Descriptive statistics, such as relative frequencies, means, and standard deviations were used to describe the dermatologist lesion classifications and management decisions for each evaluation. Overall percent agreement, kappa, and intraclass correlation were used to evaluate reader responses for lesion classification and management. Levels of interrater agreement were evaluated as percent agreement and multirater kappa. In addition, patterns of agreement for the dermatologist assessments were evaluated on the lesion level, where lesions were classified as having unanimous agreement between readers or not. Levels of classification and management accuracy were calculated for each individual reader and for the readers as a group. To describe the study sample, and to provide comparisons between measures of diagnostic performance between readers and algorithms, 2-sample tests for proportions along with chi-square tests were used. In addition, regression models for binary outcomes using a general estimating equations approach with a log link and an exchangeable correlation structure were used. In these models, readers were considered a covariate, allowing for between-reader comparisons of accuracy and stratified analyses. The exchangeable correlation structure was used to adjust the standard error estimates for the potential of clustered observations within readers. In addition, ROC curves were estimated for the individual readers and for the readers as a group. Comparisons of area under the ROC curves were performed to assess differences in reader performance and to make comparisons between the reader and algorithm performance. For dichotomous predictions, area under ROC curves is equivalent to the average of sensitivity and specificity. Alpha level was set at 5% and all presented P values are 2-sided. All analyses were performed with Stata SE software (version 14.1; Stata Corp, College Station, TX).
RESULTS
Diagnostic accuracy of dermatologists for melanoma
The average (min-max) sensitivity and specificity of the 8 readers for lesion classification (ie, benign vs. malignant) was 82% (68-98%) and 59% (34-72%), respectively (Table I) . This corresponded to an average (min-max) ROC area of 0.71 (0.61-0.76). The average (min-max) sensitivity for melanoma in situ and invasive melanoma was 68.4% (53-95%) and 89.1% (75-100%), respectively. Data describing levels of agreement among dermatologists are included in the Supplementary materials. ROC, Receiver operating characteristic; SVM, support vector machine. *Based on dichotomizing data for response. y Based on using continuous probability generated from algorithm. z Integral under a precision-recall curve (or positive predictive valueesensitivity curve).
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Diagnostic accuracy of computer algorithms
Performance of automated systems on the 100 images evaluated by the dermatologists is shown in Table II . Ranked on average precision, greedy fusion was the top performing fusion algorithm (selected 16 algorithms for fusion from the 25 total). While nonlearning methods performed similarly, more complex SVM models demonstrated a slight reduction in performance. The relearned probabilistic SVM thresholds increased sensitivity of the corresponding systems considerably. Fig 1 shows the mean probability score for the top 5 algorithms and the best performing fusion algorithm by diagnosis.
Comparison of diagnostic accuracy of dermatologists to computers
The ROC area of the best fusion computer algorithm (greedy fusion) was 0.86, which was significantly greater than the mean ROC area of 0.71 of the 8 readers in classification (P = .001). Using the dermatologist mean sensitivity value for classification (82%) as the operating point on the computer algorithm ROC curves (Figs 2, A and B) , the top fusion algorithm specificity was 76%, which was higher than the average dermatologist specificity of 59% (P = .02) and the top-ranked individual algorithm specificity of 62% (P = .13). Using the dermatologist mean sensitivity value for management (89%) as the operating point on the computer algorithm ROC curves, the fusion algorithm specificity was 64%, which was higher than the average dermatologist specificity of 47% (P = .02) and the top-ranked individual algorithm specificity of 38% (P = .009). At this cut-off threshold, there was no difference between the average dermatologist specificity and the top-ranked individual algorithm (47% vs. 38%, P = .22).
DISCUSSION
We compared the melanoma diagnostic performance of computer algorithms from an international challenge to the average performance of 8 experienced dermatologists using 100 dermoscopic images of pigmented lesions. We found that individual computer algorithms have comparable diagnostic accuracy to dermatologists; at 82% sensitivity, average reader specificity was similar to the top computer algorithm. Fusion techniques significantly improved computer performance; at 82% sensitivity, the top-ranked fusion algorithm had higher average specificity than dermatologists. In our exploratory analysis using arguably the most clinically relevant sensitivity value, the dermatologists' mean sensitivity in management decision (89%), dermatologists had specificity similar to the top algorithm, but lower than the top fusion algorithm approach. It is worth noting that some dermatologists had higher diagnostic performance than all individual and fusion algorithms in classification or management.
There has been considerable interest in developing computer vision systems for melanoma diagnosis, but few groups have directly compared computer algorithms to human performance. In 2017, Esteva et al 22 trained a deep learning convolution neural network on 129,450 images of 2032 different diseases and reported dermatologist-level classification of skin cancer. In the corresponding reader studies using clinical images (33 melanomas and 97 nevi) and dermoscopy images (71 melanomas, 40 benign), the convolution neural network had a ROC area of 0.94 and 0.91, respectively, which was superior to dermatologists. 22 In 2015, Ferris et al 8 compared the diagnostic accuracy of a computer classifier to 30 dermatology health care providers on a dataset of 65 lesions (25 melanomas, 32 nevi, 4 lentigines, and 4 seborrheic keratoses); the computer algorithm had a sensitivity of 96% and specificity of 42.5%, and the human readersdincluding dermatologists, dermatology residents, and physician assistantsdhad a mean sensitivity of 70.8% and specificity of 58.7%. In 2005, Menzies et al 11 reported on the performance of SolarScan and included a reader study of 78 lesions (13 melanomas, 63 nevi, and 2 lentigines). The computer classifier had a sensitivity In−situ (n=19) Invasive (n=31) Greedy   Fig 1. Algorithm probability scores. Mean probability score for the top 5 algorithms and best fusion algorithm (Greedy) by lesion diagnosis (ie, benign nevi or lentigines, melanoma in situ, and invasive melanoma). Probability scores from computer algorithms were in the range 0 to 1, with scores closer to 0 indicating a greater probability of a benign diagnosis and scores closer to 1 indicating a greater probability of a malignant diagnosis. The upper and lower bounds of the boxed area represent the 25th and 75th percentiles, the line transecting the box is the median value, and whiskers indicate the 5% and 95% percentiles. Dots that fall outside of the whiskers indicate extreme or outlier values.
J AM ACAD DERMATOL of 85% and specificity of 65%; this compared to a mean sensitivity and specificity of 79.5% and 50.8% for the 13 human readers. Differences in study design make comparisons of our computer algorithm results to these data challenging, highlighting the importance of creating open datasets like ours. Compared to previous investigations, there are novel aspects to our study: (1) we compared multiple computer classifiers from around the world and an aggregated model of their performance to dermatologists, increasing the likelihood that the computervision results reflect the current state-of-the-art; (2) our dataset originated from [12 dermatology clinics, possibly increasing the generalizability of our findings; (3) the readers originated from 4 countries, which may have improved the generalizability of our dermatologists' results; and (4) our dataset is public, permitting external and independent analysis and use as a future reference dataset by developers of diagnostic tools.
Our results should be interpreted with caution. A significant limitation is that our dataset did not sufficiently include: (1) the complete spectrum of skin lesions encountered in clinical practice that can mimic melanoma, including pigmented seborrheic keratoses; (2) less common presentations of melanoma, such as amelanotic, nodular, or desmoplastic types that are challenging to identify; (3) lesions from all anatomic sites, skin types, genetic backgrounds, and age ranges; and (4) a sufficiently representative group of benign lesions from which biopsy specimens would not typically be obtained or histopathologic examination conducted. It can reasonably be inferred that [99.9% of all benign skin lesions are routinely correctly classified by dermatologists (eg, nevi, angiomas, seborrheic keratoses, and lentigines), and therefore results obtained using our study design cannot be extrapolated to clinical practice. Our study setting was artificial because computer algorithms and readers did not have access to clinical data that might have improved diagnostic performance (eg, age, lesion history/symptoms, etc). 23 It has also been shown that the real-world performance of a computer-based system for melanoma in the hands of nonexperts is lower than that expected from experimental data; diagnostic accuracy depends on the ability of users to identify appropriate lesions for analysis. 24 Finally, participants of the ISBI 2016 melanoma challenge were instructed that computer algorithms would be ranked using average precision, a metric that does not target a clinically relevant sensitivity or specificity threshold; therefore, the algorithms were not optimized for comparison to dermatologist diagnostic performance.
Our results underscore the value of public challenges conducted in open-access image resources like the ISIC archive. This platform permits comparison of the performance of individual algorithms, as well as the type of fusion experiments presented here. Larger and more diverse collections of public, clinically validated images are needed to advance the field of computerized lesion classification, education, and clinical decision support. A bigger 2017 ISIC challenge represents a further step in this direction. 25 In addition to providing a larger and more diversified set of images, including seborrheic keratoses, the current challenge tailors the performance metrics for comparison to the current state of clinical diagnosis.
In conclusion, in this artificial study setting without integration of clinical history, state-of-theart computer vision systems are comparable to dermatologist diagnostic accuracy for melanoma dermoscopy images and, when using fusion algorithms, can exceed dermatologist performance in classification of some but not all dermatologists. Although these results are preliminary and should be viewed with caution, development and comparison of deep learning methods on larger, more varied datasets is likely to accelerate the potential use and adoption of computer vision for melanoma detection. Strategies for including common skin lesions from which biopsy specimens are not typically obtained in these datasets are critical for optimizing the generalizability of computer vision algorithms.
